arrow
G

Gregory J. Gores

Mayo Clinic College of Medicine and Science
H指数:164
被引数:9.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma

II期研究: futibatinib联合pembrolizumab治疗FGF19表达型晚期肝细胞癌患者的疗效观察

2026-08-250
OAAI
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma

Cell-SELEX识别了一种用于胆管癌体内高效选择性siRNA递送的DNA适体

2026-03-160
OAAI
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study

一线阿替利珠单抗/贝伐珠单抗或度伐利尤单抗/特瑞普利单抗在晚期肝细胞癌中的应用:一项真实世界、多中心回顾性研究

2025-11-010
PRE
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target

多组学结合机器学习定义了胆管癌独特的分子亚型,并鉴定了TNK1作为治疗靶点

2025-09-011
PRE
The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective study

胆道狭窄中假阴性胰胆管荧光原位杂交(PB-FISH)的发生率及预测因素:一项前瞻性研究

2025-07-210
OA
Development of the Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) Score

移植后肿瘤复发peri hilar cholangiocarcinoma复发风险估计(PRETREAT)评分的开发

2025-06-230
PRE